<p>Array technology to genotype single-nucleotide variants (SNVs) is widely used in genome-wide association studies (GWAS), clinical diagnostics, and linkage studies. Arrays have undergone a tremendous growth in both number and content over recent years making a comprehensive comparison all the more important. We have compared 28 genotyping arrays on their overall content, genome-wide coverage, imputation quality, presence of known GWAS loci, mtDNA variants and clinically relevant genes (i.e., American College of Medical Genetics (ACMG) actionable genes, pharmacogenetic genes, human leukocyte antigen (HLA) genes and SNV density). Our comparison shows that genome-wide coverage is highly correlated with the number of SNVs on the array but does not correlate with imputation quality, which is the main determinant of GWAS usability. Average imputation quality for all tested arrays was similar for European and African populations, indicating that this is not a good criterion for choosing a genotyping array. Rather, the additional content on the array, such as pharmacogenetics or HLA variants, should be the deciding factor. As the research question of a study will in large part determine which class of genes are of interest, there is not just one perfect array for all different research questions. This study can thus help as a guideline to determine which array best suits a study’s requirements.</p>

doi.org/10.1038/s41431-021-00917-7, hdl.handle.net/1765/137154
European Journal of Human Genetics
Erasmus MC: University Medical Center Rotterdam

J.A.M. (Joost) Verlouw, E (Eva) Timmermans - Clemens, J.H. (Jard) de Vries, Oliver Zolk, J.M.H. (Annemieke) Verkerk, Antoinette am Zehnhoff-Dinnesen, … L. (Linda) Broer. (2021). A comparison of genotyping arrays. European Journal of Human Genetics, 29(11), 1611–1624. doi:10.1038/s41431-021-00917-7